Sacha Macansh

736 total citations
18 papers, 421 citations indexed

About

Sacha Macansh is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Sacha Macansh has authored 18 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 3 papers in Epidemiology. Recurrent topics in Sacha Macansh's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers) and Occupational and environmental lung diseases (7 papers). Sacha Macansh is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Sarcoidosis and Beryllium Toxicity Research (9 papers) and Occupational and environmental lung diseases (7 papers). Sacha Macansh collaborates with scholars based in Australia, United Kingdom and China. Sacha Macansh's co-authors include Ian Glaspole, Yuben Moodley, E. Haydn Walters, Christopher Zappala, Tamera J. Corte, Nicole Goh, Sally Chapman, Annabelle Mahar, Paul N. Reynolds and Samantha Ellis and has published in prestigious journals such as European Respiratory Journal, Quality of Life Research and Arthritis & Rheumatology.

In The Last Decade

Sacha Macansh

18 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sacha Macansh Australia 9 384 181 44 42 33 18 421
Claudia Flexeder Germany 11 173 0.5× 146 0.8× 10 0.2× 38 0.9× 23 0.7× 19 317
Evangelia Fouka Greece 13 262 0.7× 246 1.4× 31 0.7× 11 0.3× 19 0.6× 39 382
A B Löfroos Sweden 10 565 1.5× 599 3.3× 18 0.4× 15 0.4× 38 1.2× 10 660
Denise Modina Italy 6 282 0.7× 146 0.8× 15 0.3× 14 0.3× 40 1.2× 7 334
Mary Buatti Small United States 6 396 1.0× 495 2.7× 24 0.5× 11 0.3× 13 0.4× 7 546
Gülnür Tokuç Türkiye 8 74 0.2× 48 0.3× 6 0.1× 21 0.5× 5 0.2× 31 176
Scott M. Matson United States 5 106 0.3× 59 0.3× 38 0.9× 33 0.8× 59 1.8× 20 165
C.J. Ryerson Canada 5 133 0.3× 25 0.1× 8 0.2× 27 0.6× 15 0.5× 12 174
Françoise Troussier France 7 172 0.4× 47 0.3× 7 0.2× 3 0.1× 23 0.7× 21 215
Divya Patel United States 7 128 0.3× 86 0.5× 6 0.1× 24 0.6× 25 0.8× 53 183

Countries citing papers authored by Sacha Macansh

Since Specialization
Citations

This map shows the geographic impact of Sacha Macansh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sacha Macansh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sacha Macansh more than expected).

Fields of papers citing papers by Sacha Macansh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sacha Macansh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sacha Macansh. The network helps show where Sacha Macansh may publish in the future.

Co-authorship network of co-authors of Sacha Macansh

This figure shows the co-authorship network connecting the top 25 collaborators of Sacha Macansh. A scholar is included among the top collaborators of Sacha Macansh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sacha Macansh. Sacha Macansh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jee, Adelle S., Iain Stewart, Peter Youssef, et al.. (2023). A Composite Serum Biomarker Index for the Diagnosis of Systemic Sclerosis–Associated Interstitial Lung Disease: A Multicenter, Observational Cohort Study. Arthritis & Rheumatology. 75(8). 1424–1433. 13 indexed citations
3.
Graaff, Barbara de, Julie A. Campbell, Petr Otáhal, et al.. (2022). The economic burden of idiopathic pulmonary fibrosis in Australia: a cost of illness study. The European Journal of Health Economics. 24(7). 1121–1139. 7 indexed citations
4.
Campbell, Julie A., Barbara de Graaff, Petr Otáhal, et al.. (2022). Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D. Quality of Life Research. 32(2). 473–493. 5 indexed citations
5.
Tikellis, Gabriella, Tamera J. Corte, Alan Teoh, et al.. (2021). Barriers and facilitators to best care for idiopathic pulmonary fibrosis in Australia. Respirology. 27(1). 76–84. 10 indexed citations
6.
Graaff, Barbara de, Julie A. Campbell, Petr Otáhal, et al.. (2021). The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia. Quality of Life Research. 30(9). 2615–2632. 6 indexed citations
7.
Otáhal, Petr, Barbara de Graaff, Tamera J. Corte, et al.. (2021). Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia. Respirology. 27(3). 209–216. 19 indexed citations
9.
Jo, Helen E., Tamera J. Corte, Ian Glaspole, et al.. (2019). Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry. BMC Pulmonary Medicine. 19(1). 84–84. 22 indexed citations
10.
Brannan, John D., John Attia, Kerrin Palazzi, et al.. (2019). Eligibility for anti‐fibrotic treatment in idiopathic pulmonary fibrosis depends on the predictive equation used for pulmonary function testing. Respirology. 24(10). 988–995. 5 indexed citations
11.
Jo, Helen E., Ian Glaspole, Yuben Moodley, et al.. (2018). Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry. BMC Pulmonary Medicine. 18(1). 19–19. 55 indexed citations
12.
Jo, Helen E., Ian Glaspole, Christopher Grainge, et al.. (2017). Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry. European Respiratory Journal. 49(2). 1601592–1601592. 161 indexed citations
13.
Glaspole, Ian, Sally Chapman, Wendy A. Cooper, et al.. (2017). Health‐related quality of life in idiopathic pulmonary fibrosis: Data from the Australian IPF Registry. Respirology. 22(5). 950–956. 82 indexed citations
14.
Jo, Helen E., Ian Glaspole, Christopher Grainge, et al.. (2017). Disease progression at 12 months does not predict future outcomes in IPF patients: Analysis from the Australian IPF Registry. PA852–PA852. 1 indexed citations
15.
Glaspole, Ian, Nicole Goh, Peter Hopkins, et al.. (2015). Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us?. OA4964–OA4964. 3 indexed citations
16.
Troy, Lauren, Sally Chapman, Fiona Lake, et al.. (2015). Current Australasian practice for diagnosis and management of idiopathic pulmonary fibrosis: Where are we now?. Respirology. 20(4). 647–653. 9 indexed citations
17.
Taylor, Richard, et al.. (2003). Cervical cancer screening in a Vietnamese nominal cohort. Ethnicity and Health. 8(3). 251–261. 18 indexed citations
18.
Macansh, Sacha. (2001). The role of the NSW Pap Test Register in monitoring the cervical screening process in NSW. New South Wales Public Health Bulletin. 12(4). 99–99. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026